Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 423159, 2 pages
http://dx.doi.org/10.1155/2015/423159
Editorial

Optimal Use of Biomarkers in Oncology

1Central Laboratory of Immunoanalysis, Faculty Hospital in Pilsen and Faculty of Medicine in Plzen, Charles University in Prague, 300 00 Pilsen, Czech Republic
2Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, 323 00 Pilsen, Czech Republic
3Clinical Consultants, Inc., Glen Rock, NJ 07452, USA
4Hadassah Medical Center, Hebrew University, 911 20 Jerusalem, Israel
5First Faculty of Medicine, Charles University in Prague, 121 08 Prague, Czech Republic

Received 2 July 2015; Accepted 2 July 2015

Copyright © 2015 Marie Karlikova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Marie Karlikova, Ondrej Topolcan, Olive T. J. Wolfe, Vivian Barak, and Tomas Zima, “Optimal Use of Biomarkers in Oncology,” BioMed Research International, vol. 2015, Article ID 423159, 2 pages, 2015. doi:10.1155/2015/423159